Area of research
Hepatology · Epidemiology
Research interest
Research focused on Fibrosis and Inflammation, with related work in Genotype, Cirrhosis, Toll-like receptor. Notable publications include 'The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection', 'Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease', and 'MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C'.
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
FibroGENE: A gene-based model for staging liver fibrosis
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
Identifying Motor, Emotional–Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives